Titlebook: Comparison of Type I and Type II Diabetes; Similarities and Dis Mladen Vranic,Charles H. Hollenberg,George Steiner Book 1985 The Editor(s)

conception

The Genetics of Type I and Type II Diabetes: Analysis by Recombinant DNA Methodologynent is involved in NIDDM evidenced by a high concordance in monozygotic twins. Nevertheless, there is much evidence of genetic heterogeneity. At the present time no clear cut genetic marker has been defined. The human insulin gene has been cloned and by Southern blot hybridization analysis of perip

動(dòng)作謎

為敵

Insulin-Stimulated Glucose Disposal in Patients with Type I (IDDM) and Type II (NIDDM) Diabetes Mellucose uptake characterizes patients with NIDDM, but that it could also exist in patients with IDDM. However, in the latter instance the resistance appeared to be related to degree of metabolic control, and it seemed to us that insulin sensitivity was normal in patients with IDDM well-controlled on i

scoliosis

通知

Hypomania

Insulin-Mediated and Non-Insulin-Mediated Metabolic Effects of Gastroenteropancreatic Peptides in Tyhe early 1960’s it was recognized that the glycemic stimulus to insulin secretion cannot account for differences in blood insulin levels after enteral and parenteral administration of glucose, which are also accompanied by apparent differences in glucose disposa1.. These observations revived the hor

少量

New Probes to Study Insulin Resistance in Men; Futile Cycle and Glucose Turnoverle was assessed by a double tracer method. Previously it was shown that liver glucose futile cycling is increased in diabetic dogs. In healthy control subjects in basal state and during glucose infusion, the futile cycle could not be detected, but it represented a major part of glucose metabolism in

Lice692

Atherosclerosis, the Major Complication of Diabetesf the change in mortality pattern were to be explained by prolonged survival due to the discovery of insulin, one would expect that almost all of the cardiovascular disease in diabetics should be found in type 1 (IDDM) and/or in insulin-treated type 2 diabetics. This is probably not the case. Theref

mosque

Diabetic Neuropathyissue change. Improved control of hyperglycemia does not appear to be associated with rapid neurologic improvement, possibly arguing for an intervening tissue alteration. The recently observed decrease in nerve oxygen tension and blood flow in streptozotocin diabetes suggests that an alteration of t

nerve-sparing